Enter Note Done
Go to previous page in this tab
Event
  • Scientific Session
  • Bookmark Icon
  • Rapid Toxicity Reference Values for Applied Regulatory Needs
  • Schedule
    Notes
  • Hemisfair Ballroom C3‚ Convention Center
    Set Timezone


Chair: Chelsea Weitekamp, UL Research Institutes' Chemical Insights
Co-Chair: Weihsueh Chiu, Texas A&M University

Primary Endorser: Risk Assessment Specialty Section


Endorser(s): Computational Toxicology Specialty Section


Tens of thousands of chemicals in U.S. commerce have potential human exposure but lack the toxicity values needed for human health risk assessment. At the same time, advances in exposure science and chemical prioritization have accelerated decision-making demands, creating a critical mismatch between the pace of exposure evaluation and the availability of toxicity benchmarks. Traditional human health assessments require substantial time and data and cannot be feasibly conducted at the scale required for modern regulatory and screening needs.

Database-Calibrated Toxicity Values (dCTVs) address this challenge by providing a rapid, data-driven approach for deriving toxicity values from curated in vivo data using standardized and transparent methods. Initial applications of the dCTV framework successfully generated chronic oral toxicity values for over 1,000 chemicals, demonstrating the feasibility of scalable toxicity value development.

This session focuses on the extension of the dCTV framework to inhalation exposures, an area of acute need for state and local agencies responsible for evaluating air toxics. These programs must screen large chemical inventories, address emerging contaminants, and support community-level air quality decisions under significant time and resource constraints. Inhalation dCTVs offer a practical solution by enabling the generation of scientifically grounded toxicity values at scale to support prioritization, screening, and risk-informed decision-making.

The session will first present the scientific foundation of inhalation dCTVs, including curated database integration, standardized dosimetry and extrapolation approaches, empirical calibration to existing expert-selected points of departure, and explicit uncertainty characterization. Subsequent presentations will highlight real-world applications in California and Texas, demonstrating how dCTVs can be implemented within distinct regulatory frameworks to support air toxics evaluation. These case studies illustrate how the approach can be flexibly applied across varying policy contexts, exposure scenarios, and programmatic needs.

Beyond state air toxics programs, the dCTV framework is broadly applicable to any context requiring rapid toxicity value generation under resource constraints, including federal risk assessment, emergency response, chemical prioritization, alternatives assessment, and industry-led safety evaluations. This cross-sector relevance underscores the potential for dCTVs to serve as a unifying approach for scalable, transparent toxicity assessment.

This session is designed for regulatory toxicologists, risk assessors, exposure scientists, and decision-makers across government, industry, and nonprofit sectors. Attendees will gain (1) a clear understanding of the scientific basis and assumptions underlying dCTVs, (2) insight into how these methods complement traditional toxicity assessments, and (3) practical knowledge of how dCTVs could be implemented within diverse regulatory and risk assessment contexts to address data gaps and accelerate decision-making.

By directly addressing the imbalance between data availability and decision needs, inhalation dCTVs represent a significant innovation in applied toxicology. This session will demonstrate how scalable toxicity value development can enhance risk-based decision-making and provide attendees with the tools to evaluate and adopt these approaches in their own work.



IAT ITS Designation: Innovations in Applied Toxicology (IAT)
Session and Activity Type
Presentations